| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.52.4.738 |
| P8608 | Fatcat ID | release_qgxv3ttx2ffehnnonyb4itldp4 |
| P698 | PubMed publication ID | 10078719 |
| P50 | author | John Paul Leach | Q58424785 |
| P2093 | author name string | D W Chadwick | |
| J B Miles | |||
| I K Hart | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rasmussen's encephalitis | Q1637701 |
| P304 | page(s) | 738-742 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy | |
| P478 | volume | 52 |
| Q47112083 | A Case Series of Adult-Onset Rasmussen's Encephalitis: Diagnostic and Therapeutic Challenges |
| Q34707001 | Advances in pathogenic concepts and therapeutic agents in Rasmussen's encephalitis |
| Q36153418 | Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy |
| Q48799486 | Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study |
| Q37032549 | Antiepileptic drug development in children: considerations for a revisited strategy |
| Q37203376 | Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. |
| Q34733326 | Autoantibody-mediated disorders of the central nervous system |
| Q37578846 | Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy. |
| Q48552656 | Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis |
| Q90095654 | Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome |
| Q38422840 | Epilepsy surgery in adult-onset Rasmussen's encephalitis: case series and review of the literature. |
| Q37696997 | Eponym : Rasmussen syndrome |
| Q33385332 | Evidence for the use of intravenous immunoglobulins--a review of the literature |
| Q47919182 | Extrarolandic electroclinical findings in the evolution of adult-onset Rasmussen's encephalitis. |
| Q34458405 | Future prospects for the drug treatment of epilepsy. |
| Q38235715 | Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep |
| Q26825778 | Hemispherectomy in the treatment of seizures: a review |
| Q43681755 | High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases |
| Q52720739 | Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis. |
| Q34574581 | Intravenous immunoglobulin in neurological disease: a specialist review. |
| Q59413122 | La place des immunoglobulines intraveineuses en neurologie |
| Q31115874 | Late onset Rasmussen's syndrome: clinical and therapeutic characteristics |
| Q39753625 | Perfusion IMP-SPECT shows reversible abnormalities in GABA(B) receptor antibody associated encephalitis with normal MRI. |
| Q47106266 | Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis |
| Q51662107 | Rasmussen encephalitis: long-term outcome after surgery. |
| Q74582976 | Rasmussen's Encephalitis |
| Q31062383 | Rasmussen's encephalitis in a 58-year-old female: still a variant? |
| Q38701350 | Rasmussen's encephalitis: advances in management and patient outcomes |
| Q30741122 | Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. |
| Q44683891 | Recent advances in pathogenic concepts and therapeutic strategies in Rasmussen's encephalitis |
| Q48536481 | The natural history of Rasmussen's encephalitis |
| Q34153289 | Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis. |
| Q53646088 | [Rasmussen's syndrome, an autoimmune disease] |
| Q81913993 | [Recent insights into Rasmussen encephalitis] |
| Q80257893 | [Use of i.v. immunoglobulins in neurology. Evidence-based consensus] |
Search more.